Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study.Journal of Psychopharmacology · 2026-07-22Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-21Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition - Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)Zenodo (CERN European Organization for Nuclear Research) · 2026-07-13Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-12Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Unknown journal · 2026-06-30Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.Unknown journal · 2026-06-30Therapeutic advances in fibromyalgia: one year in review 2026.Unknown journal · 2026-06-16Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.Unknown journal · 2026-06-07Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-01Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative StudyBrain and Behavior · 2026-05-31Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective OutcomesBrain and Behavior · 2026-05-31Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network AnalysisJournal of Pain and Symptom Management · 2026-05-11Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.Unknown journal · 2026-04-21A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of ActionPharmacology Research & Perspectives · 2026-03-31Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)Brain Sciences · 2026-03-25The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS DisordersCNS & Neurological Disorders - Drug Targets · 2026-03-10Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic PainJournal of Pain · 2026-02-28Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-17Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-01-31Participant Experiences of Therapeutic Touch in Psilocybin-Assisted TherapyBrain and Behavior · 2026-01-31Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and AccessBrain and Behavior · 2026-01-31Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-01-23Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-08Preclinical evaluation of psilocybin as an anti-inflammatory agentNeuroscience Applied · 2025-12-31Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)Psychiatry Research · 2025-12-28Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trialHeadache The Journal of Head and Face Pain · 2025-12-28Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challengesMycological Progress · 2025-12-07Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyUnknown journal · 2025-11-30Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid rewardNature Communications · 2025-11-19Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticityNeuropsychopharmacology · 2025-11-11Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Unknown journal · 2025-10-22Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteerJournal of Psychopharmacology · 2025-10-15Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29With great power comes great responsibility: Promise and caution in the new psychedelic renaissanceBrain Disorders · 2025-09-22Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-15Interventions to support spirituality among adults with cancer: a scoping review.Unknown journal · 2025-08-01Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED surveyJournal of Eating Disorders · 2025-07-23Psilocybin as a psychophysical adaptogen in chronic pain rehabilitationJournal of Pain · 2025-07-20The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Unknown journal · 2025-07-17Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat SettingsBrain and Behavior · 2025-06-30Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stressTranslational Psychiatry · 2025-06-13Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-28Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health TreatmentJournal of Psychoactive Drugs · 2025-05-28Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Unknown journal · 2025-04-1413. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08Pictorial Representation of Illness and Self Measure: A Putative Transdiagnostic Tool for Evaluating Therapeutic Effects of Psilocybin-Assisted Therapy in FibromyalgiaJournal of Pain · 2025-03-31Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic PainJournal of Pain · 2025-03-31Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortexMolecular Brain · 2025-03-17Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.Unknown journal · 2025-03-17IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic painPharmacological Research · 2025-03-16Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Psychedelics and Suicide-Related Outcomes: A Systematic Review.Unknown journal · 2025-02-19Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic useBritish Journal of Pain · 2025-02-10Psilocybin induces sex- and context-specific recruitment of the stress axisbioRxiv · 2025-01-05Uncovering the dynamics of psilocybin in human neural pain circuits with intracranial neural recordingsBrain stimulation · 2024-12-31High-quality draft genomes of ecologically and geographically diverse Psilocybe speciesMicrobiology Resource Announcements · 2024-12-26Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic SurveyJournal of Psychoactive Drugs · 2024-12-23The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-09Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) TrialCanadian Journal of Pain · 2024-11-07Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of UseJournal of Psychoactive Drugs · 2024-11-05Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-08Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-09-19Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and miceNeuroscience · 2024-09-02Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case reportFrontiers in Psychiatry · 2024-07-15The trajectory of psychedelic, spiritual, and psychotic experiences: implications for cognitive scientific perspectives on religionReligion Brain & Behavior · 2024-07-10Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.Journal of Clinical Oncology · 2024-05-31Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in ratsBrain · 2024-05-03Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.Unknown journal · 2024-04-16Pharmacology of Classical Psychedelic in Mouse Models of Chronic PainJournal of Pain · 2024-03-31Scoping Review: The Role of Psychedelics in the Management of Chronic PainJournal of Pain Research · 2024-02-29UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional studyBMJ Open · 2024-02-29Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy PersistsAJOB Neuroscience · 2024-02-04Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse modelNeuroscience Applied · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent ratsTranslational Psychiatry · 2023-12-13Aesthetic Chills Mitigate Maladaptive Cognition In DepressionResearch Square · 2023-11-13Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-06Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatmentBrain Behavior and Immunity · 2023-10-31Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Unknown journal · 2023-10-10Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-04Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Unknown journal · 2023-10-04Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled studyBrain Behavior and Immunity · 2023-09-06Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.Psychedelic medicine (New Rochelle, N.Y.) · 2023-08-31Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Potential analgesic effects of psychedelics on select chronic pain conditions: A survey studyEuropean Journal of Pain · 2023-08-19The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility StudyClinicalTrials.gov · 2023-07-26A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18A systematic review to assess the use of psilocybin in the treatment of headachesUnknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Psychedelics reopen the social reward learning critical periodNature · 2023-06-13HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerJournal of Pain and Symptom Management · 2023-06-09Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-01ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-05-31Psychedelics promote plasticity by directly binding to BDNF receptor TrkBNature Neuroscience · 2023-05-31Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-17A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapymedRxiv · 2023-04-18118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-04Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorderJournal of Psychiatric Research · 2023-03-27Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.Unknown journal · 2023-03-21The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2022-12-31Visualizing drug actions on dendrites: psilocybin and other classic psychedelicsUnknown journal · 2022-12-31Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathwayFungal Genetics and Biology · 2022-12-28Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache The Journal of Head and Face Pain · 2022-11-22Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Five new species of Inosperma from China: Morphological characteristics, phylogenetic analyses, and toxin detection.Frontiers in Microbiology · 2022-10-30Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)Journal of Anesthesiology and Pain Therapy · 2022-10-02A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Unknown journal · 2022-10-02If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.The journal of pain · 2022-09-30Microdosing psilocybin for chronic pain: a case series.Pain · 2022-09-04The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Unknown journal · 2022-08-16Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?Expert opinion on drug safety · 2022-05-31Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain · 2022-03-31An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of traumaDrug Science Policy and Law · 2021-12-31Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.Frontiers in psychiatry · 2021-12-31Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2021-12-31Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia NervosaOBM Neurobiology · 2021-06-23A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature reviewBrazilian Journal of Health Review · 2021-05-02Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in miceBehavioural Brain Research · 2020-12-27MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogensNeuropsychopharmacology · 2020-11-19The Role of Psychedelics and Counseling in Mental Health TreatmentJournal of Mental Health Counseling · 2020-09-30P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlapHuman Brain Mapping · 2020-08-20Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapseNeuropsychopharmacology · 2020-05-04P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low dosesEuropean Neuropsychopharmacology · 2019-11-30Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreatScientific Reports · 2019-10-23Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Taking Psychedelics Seriously (TH316)Journal of Pain and Symptom Management · 2018-01-31Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological DistressWestern CEDAR (Western Washington University) · 2017-12-31LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Psychedelic Drugs in Biomedicine.Unknown journal · 2017-09-21Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-07-11Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma modelsThe FASEB Journal · 2017-03-31Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30MAGIC MUSHROOMS: from sacred entheogen to Class A drugEntertainment and Sports Law Journal · 2016-06-26Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European Neuropsychopharmacology · 2016-01-21P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteersEuropean Neuropsychopharmacology · 2015-08-31The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.Neuropharmacology · 2015-07-16Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human Brain Mapping · 2015-05-21The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-makingEuropean Psychiatry · 2015-02-28P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24Enhanced repertoire of brain dynamical states during the psychedelic experience.Human Brain Mapping · 2014-07-02Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.Journal of psychopharmacology (Oxford, England) · 2013-12-31Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.Experimental Brain Research · 2013-06-01Effects of psilocybin on the human brain functional networkFigshare · 2012-12-31Effects of a Psychedelic, Tropical Tea, Ayahuasca, on the Electroencephalographic (EEG) Activity of the Human Brain during a Shamanistic RitualUnknown journal · 2000-12-31Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-olsJournal of Heterocyclic Chemistry · 1977-01-31ChemInform Abstract: NEUER ZUGANG ZU PSILOCIN-DERIVATENChemischer Informationsdienst · 1974-12-09